Price data is not available
Nanobiotix SA
NBTXNASDAQ
Nanobiotix rose 56.2% from $21.10 to $32.95, ahead of the S&P 500's +11.2%. Its worst day was Mar 11 (−14.0%), and its low came Jan 8 at $19.97.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Nanobiotix closed at its lowest level of the year, 5.4% below where the year started.
−7.0% · S&P 500 0.0%
Nanobiotix shares rose 18.1%, while the S&P 500 rose 0.9%.
+18.1% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
EPS of $-0.58 was reported on $37.9M revenue (est. $165.5M).
+10.4% · S&P 500 +0.8%
Nanobiotix shares rose 20.4%, while the S&P 500 rose 1.4%.
+20.4%, the year's best day · S&P 500 +1.4%
Nanobiotix closed at its highest level of the year, 161.0% above where the year started.
+5.8% · S&P 500 +0.8%
EPS of $-0.82 was reported on $6.5M revenue.
−0.4% · S&P 500 +0.5%
Nanobiotix shares rose 14.5%, while the S&P 500 rose 0.3%.
+14.5% · S&P 500 +0.3%
Where it ended: a close of $32.95 on Nov 11, 2026.
Nothing in the past 12 months.
All NBTX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NBTX and SPY from Benzinga historical bars. Not investment advice.
